Lv31
330 积分 2022-05-18 加入
Fenofibrate inhibits MOXD1 and PDZK1IP1 expression and improves lipid deposition and inflammation in mice with alcoholic fatty liver
2小时前
待确认
Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD
14天前
已完结
Fenofibrate inhibits MOXD1 and PDZK1IP1 expression and improves lipid deposition and inflammation in mice with alcoholic fatty liver
17天前
已完结
Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases
30天前
已完结
Plasma proteomics identifies proteins and pathways associated with incident depression in 46,165 adults
30天前
已完结
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions
1个月前
已完结
Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis
1个月前
已完结
Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study
1个月前
已完结
Analysis of clinical efficacy and long-term prognosis of patients with hepatocellular carcinoma treated with PD-L1 inhibitor targeting
2个月前
已完结
Meta-analysis of the GALAD model for diagnosing primary hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
